Find similar content

Source channel @githubtrending · Post #14821 · Jun 11

#typescript#editor#gfm#javascript#markdown#markdown_editor#milkdown#prosemirror#remarkjs#rich_text_editor#typescript#wysiwyg#wysiwyg_editor Milkdown is a flexible, open-source editor that lets you write and edit Markdown in a simple, visual way, just like you see it in apps such as Typora. It is built using powerful tools like ProseMirror and Remark, and everything in Milkdown works as a plugin, so you can add or remove features easily. You can customize its look and feel to match your app, and it supports real-time collaboration for team editing. This means you get a reliable, easy-to-use editor that fits your needs and grows with your projects, making writing and sharing documents smoother and more efficient[1][2][4]. https://github.com/Milkdown/milkdown

Hashtags

#typescript #editor #gfm #javascript #markdown #markdown_editor #milkdown #prosemirror #remarkjs #rich_text_editor #wysiwyg #wysiwyg_editor

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment